Membrane composition modulates the interaction between a new class of antineoplastic agents deriving from aromatic 2-chloroethylureas and lipid bilayers: a solid-state NMR study

Chemistry and Physics of Lipids

Volumn 146, Issue 2, 2007, Pages 125-135

  Cronier, Francis ^a   Patenaude, Alexandre ^b   C Gaudreault, René ^b   Auger, Michèle ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b Université Laval   (Canada)

Author keywords

Arylchloroethylureas; Cardiolipin; Endoplasmic reticulum; Mitochondria; Model membranes; Solid state NMR spectroscopy

Indexed keywords

1 (2 CHLOROETHYL) 3 (4 CYCLOHEXYLPHENYL)UREA; 1 (2 CHLOROETHYL) 3 (4 HEPTYLPHENYL)UREA; 1 (2 CHLOROETHYL) 3 [3 (HYDROXYPENTYL)PHENYL]UREA; 1 (4 TERT BUTYLPHENYL) 3 (2 CHLOROETHYL)UREA; 1 (4 TERT BUTYLPHENYL) 3 ETHYLUREA; 2 CHLOROETHYLUREA DERIVATIVE; 4 CYCLOPHENYL(4,5 DIHYDROOXAZOL 2 YL)AMINE; 4 HEPTYLPHENYL(4,5 DIHYDROOXAZOL 2 YL)AMINE; ANTINEOPLASTIC AGENT; CARDIOLIPIN; CHOLESTEROL; DEUTERIUM; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PHOSPHORUS 31; SPHINGOMYELIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CHEMICAL STRUCTURE; ENDOPLASMIC RETICULUM; LIPID BILAYER; MEMBRANE MODEL; MITOCHONDRIAL MEMBRANE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SOLID STATE NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ANTINEOPLASTIC AGENTS; LIPID BILAYERS; MAGNETIC RESONANCE SPECTROSCOPY; UREA;

VASCONCELLEA CANDICANS;

EID: 33847182465     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2007.01.002     Document Type: Article

References (39)

1. Béchard P., Lacroix J., Poyet P., and C.-Gaudreault R. Synthesis and cytotoxic activity of new alkyl 3-(2-chloroethyl(ureido))benzene derivatives. Eur. J. Med. Chem. 29 (1994) 963-966
2. Bennett A.E., Rienstra C.E., Auger M., Lakshmi K.V., and Griffin R.G. Heteronuclear decoupling in rotating solids. J. Chem. Phys. 103 (1995) 6951-6958
3. Bouchon B., Chambon C., Mounetou E., Papon J., Miot-Noirault E., C.-Gaudreault R., Madelmont J.-C., and Degoul F. Alkylation of beta-tubulin on Glu 198 by a microtubule disrupter. Mol. Pharmacol. 68 (2005) 1415-1422
4. C.-Gaudreault R., Alaoui-Jamali M.A., Batist G., Béchard P., Lacroix J., and Poyet P. Lack of cross-resistance to a new cytotoxic arylchloroethyl urea in various drug-resistant tumor cells. Cancer Chemother. Pharmacol. 33 (1994) 489-492
5. C-Gaudreault R., Lacroix J., Pagé M., and Joly L.P. 1-Aryl-3-(2-chloroethyl) ureas: synthesis and in vitro assay as potential anticancer agents. J. Pharm. Sci. 77 (1988) 185-187
6. Colell A., Garcia-Ruiz C., Lluis J.M., Coll O., Mari M., and Fernandez-Checa J.C. Cholesterol impair the adenine nucleotide translocator-mediated mitochondrial permeability transition through altered membrane fluidity. J. Biol. Chem. 278 33 (2003) 928-933, 935
7. Colombini M. VDAC: the channel at the interface between mitochondria and the cytosol. Mol. Cell. Biochem. 256/257 (2004) 107-115
8. Cullis P.R., and de Kruijff B. Lipid polymorphism and the functional roles of lipids in biological membranes. Biochim. Biophys. Acta 559 (1979) 339-420
9. Davis J.H. Deuterium magnetic resonance study of the gel and liquid crystalline phases of dipalmitoyl phosphatidylcholine. Biophys. J. 27 (1979) 339-358
10. Davis J.H., Jeffrey K.R., Bloom M., and Valic M.I. Quadrupolar echo deuteron magnetic resonance spectrsocopy in ordered hydrocarbon chains. Chem. Phys. Lett. 42 (1976) 390-394
11. Gicquaud C., Auger M., Wong P.T.T., Poyet P., Boudreau N., and C.-Gaudreault R. Interaction of 4-tert- butyl- 3-(2-chloroethyl) ureido benzene with phosphatidylcholine bilayers: a differential scanning calorimetry and infrared spectroscopy study. Arch. Biochem. Biophys. 334 (1996) 193-199
12. Godeneche D., Labarre P., Moreau M.F., Madelmont J.-C., Rapp M., Papon J., and Veyre A. Main urinary metabolites of two cysteamine-containing 2-(chloroethyl)nitrosoureas in rats. Drug Metab. Dispos. 21 (1993) 93-99
13. Godeneche D., Madelmont J.-C., Moreau M.F., Duprat J., Chabard J.L., Plagne R., and Meyniel G. Metabolic disposition of 2-chloroethylnitrosocarbamoycystamine in rats. Drug Metab. Dispos. 13 (1985) 220-226
14. Grunicke H., Grünewald K., Helliger W., Scheidl F., Wolff-Schreiner E., and Puschendorf B. Inhibition of tumor growth by an alkylation of the plasma membrane. Adv. Enzym. Regul. 21 (1983) 21-30
15. Guard-Friar D., Chen C.-H., and Engle A.S. Deuterium isotope effect on the stability of molecules: phospholipids. J. Phys. Chem. 89 (1985) 1810-1813
16. Hahn E.L. Spin echoes. Phys. Rev. 80 (1950) 580-594
17. Ihlenfeldt M., Gantner G., Harrer M., Puschendorf B., Putzer H., and Grunicke H. Interaction of the alkylating antitumor agent 2,3,5-tris(ethyleneimino)benzoquinone with the plasma membrane of Ehrlich ascites tumor cells. Cancer Res. 41 (1981) 289-293
18. Korsnes M.S., Hetland D.L., Espenes A., and Aune T. Induction of a apoptosis by YTX in myoblast cell lines via mitochondrial signalling transduction pathway. Toxicol. in Vitro 20 (2006) 1419-1426
19. Lacroix J., C.-Gaudreault R., Pagé M., and Joly L.P. In vitro and in vivo activity of 1-aryl-3-(2-chloroethyl) ureas derivatives as new antineoplastic agents. Anticancer Res. 8 (1988) 595-598
20. Laws D.D.L., Bitter H.M., and Jerschow A. Solid-state NMR spectroscopic methods in chemistry. Angew. Chem. Int. Ed. 41 (2002) 3096-3129
21. Legault J., Gaulin J.-F., Mounetou E., Bolduc S., Lacroix J., Poyet P., and C.-Gaudreault R. Microtubule disruption induced in vivo by alkylation of β-tubulin by 1-aryl-3-(2-chloroethyl)ureas, a novel class of soft alkylating agents. Cancer Res. 60 (2000) 985-992
22. Lipinski C.A., Lombardo F., Dominy B.W., and Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development setting. Adv. Drug Delivery Rev. 23 (1997) 3-25
23. MacRae T.H., and Langdon C.M. Tubulin synthesis, structure, function: what are the relationship?. Biochem. Cell Biol. 67 (1989) 770-790
24. Maurizis J.-C., Rapp M., Azim E.M., C.-Gaudreault R., Veyre A., and Madelmont J.-C. Disposition and metabolism of a novel antineoplastic agent, 4-tert-butyl-3-(2-chloroethyl) ureido] benzene, in mice. Drug Metab. Dispos. 26 (1998) 146-151
25. Mounetou E., Legault J., Lacroix J., and C.-Gaudreault R. Antimiotic antitumor agents: synthesis, structure-activity relationships, and biological characterization of n-aryl-n-(2-chloroethyl)ureas as new selective alkylating agents. J. Med. Chem. 44 (2001) 694-702
26. Mounetou E., Legault J., Lacroix J., and C.-Gaudreault R. Antimiotic antitumor agents: a new generation of n-aryl-n-(1-alkyl-2-chloroethyl)ureas as microtubule disruptors: synthesis, antiproliferative activity, and β-tubulin alkylation. J. Med. Chem. 46 (2003) 5055-5063
27. Petitclerc E., Deschesnes R.G., Côté M.-F., Marquis C., Janvier R., Lacroix J., Miot-Noirault E., Legault J., Mounetou E., Madelmont J.-C., and C.-Gaudreault R. Antiangenic and antitumoral activity of phenyl-3-(2-chloroethyl)ureas: a new class of soft alkylating agents disrupting microtubules that are unaffected by cell adhesion-mediated drug resistance. Cancer Res. 64 (2004) 1-10
28. Poyet P., Ritchot N., Béchard P., and C.-Gaudreault R. Effect of an aryl chloroethyl ureas on tubulin and vimentin syntheses in human breast cancer cell line. Anticancer Res. 13 (1993) 1447-1452
29. 2H solid-state NMR study. Biochem. Cell Biol. 76 (1998) 465-471
30. Saint-Laurent A., Boudreau N., Larivière D., Legault J., C.-Gaudreault R., and Auger M. Membrane interactions of a new class of anticancer agents derived from arylchloroethylurea: a FTIR spectroscopic study. Chem. Phys. Lipids 111 (2001) 163-175
31. Seelig J. Deuterium magnetic resonance: theory and application to lipid membranes. Q. Rev. Biophys. 10 (1977) 353-418
32. 31P nuclear magnetic resonance and the head group structure of phospholipids in membranes. Biochim. Biophys. Acta 515 (1978) 105-140
33. Seelig J., and Seelig A. Lipid conformation in model membrane and biological membranes. Q. Rev. Biophys. 13 (1980) 19-61
34. Smith I.C.P., and Ekiel I.H. Phosphorus-31 NMR of phospholipids in membranes. In: Gorenstein D.G. (Ed). In Phosphorus-31 NMR: Principles and Applications (1984), Academic Press, London 447-475
35. Tzagoloff A. Mitochondria (1982), Academic Press, New York
36. van den Brink-van der Laan E., Killian J.A., and de Kruijff B. Nonbilayer lipids affect peripheral and integral membrane proteins via changes in the lateral pressure profile. Biochim. Biophys. Acta 1666 (2004) 275-288
37. Vance D.E., and Vance J.E. Biochemistry of Lipids, Lipoproteins and Membranes (1996), Elsevier, New York
38. Warschawski D.E., Traikia M., Devaux P.F., and Bodenhausen G. Solid-state NMR for the study of membrane systems: the use of anisotropic interactions. Biochimie 80 (1998) 437-450
39. Zhirnov A.E., Demina T.V., Krylova O.O., Grozdova I.D., and Melik-Nubarov N.S. Lipid composition determines interaction of liposome membranes with Pluronic L61. Biochim. Biophys. Acta 1720 (2005) 73-83